NCT03209362View on ClinicalTrials.gov

SI-613 Study for Knee Osteoarthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 19, 2017

Primary Completion Date

August 17, 2018

Study Completion Date

November 13, 2018

Conditions
Osteoarthritis, Knee
Interventions
COMBINATION_PRODUCT

SI-613

SI-613 will be repeated intra-articularly administered.

COMBINATION_PRODUCT

Placebo

Placebo will be repeated intra-articularly administered.

Trial Locations (10)

14221

Upstate Clinical Research Associates, LLC, Williamsville

14609

Rochester Clinical Research, Rochester

16635

Altoona Center for Clinical Research, Duncansville

33185

MM Medical Center, Inc., Miami

33186

Quality Research and Medical Center, LLC, Miami

40509

Central Kentucky Research Associates, Lexington

45242

New Horizons Clinical Research, Cincinnati

63141

Sundance Clinical Research, LLC, St Louis

67114

Heartland Research Associates, LLC, Newton

85712

Tucson Orthopaedic Institute, Tucson

Sponsors
All Listed Sponsors
collaborator

Chiltern International Inc.

INDUSTRY

lead

Seikagaku Corporation

INDUSTRY